Cybin D/B/A Helus Pharma HELP
8.38 USD -0.30 (-3.46%)
Nov 5, 2026, 3:56 PM EST
8.20 Day range 8.75
3.76 52-week range 15.15
- YTD
- +2.44%
- 1 year
- +40.84%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -142.59M | -103.13M | -78.84M | -51.52M | -63.84M | |
| -148.00M | -81.61M | -78.08M | -47.49M | -67.63M | |
| -4.25 | -4.04 | -9.41 | -9.90 | -15.20 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 157.26M | 93.92M | 208.99M | 16.63M | 53.64M | |
| 251.17M | 179.90M | 302.02M | 53.90M | 84.06M | |
| 19.38M | 14.90M | 10.10M | 5.66M | 7.91M | |
| 231.79M | 165.00M | 291.93M | 48.23M | 76.16M |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -133.27M | -72.33M | -68.91M | -47.43M | -45.21M | |
| -1.36M | -1.40M | 6.92M | -3.31M | -770.00K | |
| 198.24M | 14.10M | 254.51M | 13.56M | 35.78M | |
| -1.36M | -1.40M | -710.00K | -142.00K | -105.00K | |
| 63.34M | -60.32M | 192.36M | -37.01M | -10.38M |